Daily non-political popular news in brief.

Fixing Drug Safety System Will Require 'New Drug' Symbol On Labels

09-29-2006 · ScienceDaily

Lack of clear regulatory authority, chronic underfunding, organizational problems, and a scarcity of post-approval data about drugs' risks and benefits have hampered the U.S. Food and Drug Administration's ability to evaluate and address the safety of prescription drugs after they have reached the market, says a new report from the Institute of Medicine.

Keywords: fixing, drug, safety, system, require, symbol, labels, label

« Previous | Next »

Similar news on "Fixing Drug Safety System Will Require 'New Drug' Symbol On Labels":

Drug surveillance system needs to be fixed
06-14-2007 · EurekAlert!
The current drug surveillance system needs to be fixed, argues an editorial in this week' BMJ.The call follows a recent analysis of the diabetes drug rosiglitazone which raised serious questions about the drug's safety.
Similar news · Read more »
Marine scientists warn human safety, prosperity depend on better ocean observing system
11-25-2007 · EurekAlert!
An eminent partnership of international ocean scientists call for an adequate initial system to produce insights, forecasts useful to public, policy makers. They say warming seas, over-fishing and pollution are among profound concerns that must be better measured to help society respond in a well-informed, timely and cost-effective way. Cost of an initial adequate system would require a further investment estimated at $2-3 billion.
Similar news · Read more »
System of simplified, standardized dosing instructions for prescription drug labels proposed
11-28-2007 · EurekAlert!
At today's Sixth Annual National Health Communication Conference co-sponsored by the American College of Physicians Foundation and the Institute of Medicine, Alastair J.J. Wood, M.D., F.A.C.P., proposed an evidence-based system of simplified, standardized dosing instructions for prescription medication container labels.
Similar news · Read more »
Second-generation drug-eluting stent system challenges current gold standard
03-24-2007 · EurekAlert!
While research shows that drug-eluting stents effectively reduce restenosis and revascularization compared to bare-metal stents, questions surrounding the safety of drug-eluting stents continue to dominate headlines. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit surveys the safety and efficacy of the second generation Xience Everolimus Eluting Coronary Stent System (EES), compared to the current gold standard paclitaxel-eluting stent (PES), to determine if it offers similar or enhanced outcomes.
Similar news · Read more »
UC San Diego researchers give computers 'common sense'
10-17-2007 · EurekAlert!
Using a little-known Google Labs widget, computer scientists from UC San Diego and UCLA have brought common sense to an automated image labeling system. This common sense is the ability to use context to help identify objects in photographs. For example, if a conventional automated object identifier labels a person, a tennis racket, a tennis court and a lemon in a photo, the new post-processing context check will re-label the lemon a tennis ball.
Similar news · Read more »
Effectiveness of over-the-counter decongestant questioned in new study
01-31-2007 · EurekAlert!
The only over-the-counter (OTC) oral decongestant currently available without restriction may be less effective than previously thought, according to a new study. This meta-analysis of 15 previous studies concludes that the standard 10 mg dose of the drug, found in popular products such as Actifed, Sudafed PE, and Tylenol Sinus, appears to be no more effective than placebo and suggests that the FDA should require additional studies to prove the drug's safety and efficacy.
Similar news · Read more »
Drug safety recommendations lack scientific evidence
02-21-2007 · EurekAlert!
During the past several years, there has been a perceived drug safety crisis in the United States. The Institute of Medicine (IOM), recently released it final recommendations for reforming the US drug safety system, but an editorial published today in Health Economics by Tomas Philipson and colleagues at the University of Chicago finds little evidence of a drug safety crisis and no scientific evidence to back up the IOM's recommendations.
Similar news · Read more »
New Analyses of long-term LIALDA (mesalamine) data presented at ACG
10-15-2007 · EurekAlert!
Post-hoc and other analyses of secondary endpoints of a long-term safety and tolerability study of Shire plc's ulcerative colitis drug LIALDA (mesalamine) provide further data on LIALDA in patients with mild to moderate ulcerative colitis. These analyses of LIALDA's 303 trial, a long-term, Phase III, open-label 12-14 month extension study, are being presented this week at the American College of Gastroenterology meeting in Philadelphia.
Similar news · Read more »
Drug labels are prescriptions for mistakes
11-29-2006 · EurekAlert!
A new study to assess understanding of five common prescription label instructions found that patients had difficulty comprehending how much and how often the medication should be taken. Misunderstanding was particularly high among those with lower literacy (eighth grade level or below) and those who took many prescription drugs.
Similar news · Read more »
Second generation drug-eluting stent system challenges current gold standard
03-24-2007 · EurekAlert!
While research shows that drug-eluting stents effectively reduce restenosis and revascularization compared to bare-metal stents, questions surrounding the safety of drug-eluting stents continue to dominate headlines. A study presented today at the American College of Cardiology’s Innovation in Intervention: i2 Summit surveys the safety and efficacy of the second generation Xience Everolimus Eluting Coronary Stent System (EES), compared to the current gold standard paclitaxel-eluting stent (PES), to determine if it offers similar or enhanced outcomes.
Similar news · Read more »